(Q43967144)

28 November 2017

Effect of PPARgamma ligands on the viability of gastric epithelial cells (English)

1 reference

28 November 2017

Kojima K

1

1 reference

28 November 2017

Shimada T

2

1 reference

28 November 2017

Mitobe Y

3

1 reference

28 November 2017

Yoshiura K

4

1 reference

28 November 2017

Hiraishi H

5

1 reference

28 November 2017

Terano A

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Alimentary Pharmacology & Therapeutics

28 November 2017

1 reference

28 November 2017

16 Suppl 2

1 reference

28 November 2017

67-73

1 reference

Medical significance of peroxisome proliferator-activated receptors.

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

21 January 2018

Regulating adipogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Activators of the nuclear receptor PPARgamma enhance colon polyp formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.16.S2.16.X

10.1046/J.1365-2036.16.S2.16.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference